Businesses
Here's a look at documents from U.S. and international businesses
Featured Stories
Premium Matchups Headline 2026 Sunday Night Baseball Schedule as MLB Returns to NBC and Peacock
NEW YORK, Jan. 10 [Category: BizMedia] -- NBCUniversal, a subsidiary of Comcast, posted the following news:
* * *
Premium Matchups Headline 2026 Sunday Night Baseball Schedule as MLB Returns to NBC and Peacock
Reigning MVPs Shohei Ohtani and Aaron Judge, storied rivalries, top division matchups, and '25 Postseason Clubs meeting in a scorching summer stretch of five consecutive NBC Sunday nights (June 28-Aug. 2) highlight NBC Sports ' 2026 Major League Baseball schedule.
NBC Sports' 2026 MLB schedule features:
* 27 primetime games, a mixture of Sunday Night Baseball and holiday/special event
... Show Full Article
NEW YORK, Jan. 10 [Category: BizMedia] -- NBCUniversal, a subsidiary of Comcast, posted the following news:
* * *
Premium Matchups Headline 2026 Sunday Night Baseball Schedule as MLB Returns to NBC and Peacock
Reigning MVPs Shohei Ohtani and Aaron Judge, storied rivalries, top division matchups, and '25 Postseason Clubs meeting in a scorching summer stretch of five consecutive NBC Sunday nights (June 28-Aug. 2) highlight NBC Sports ' 2026 Major League Baseball schedule.
NBC Sports' 2026 MLB schedule features:
* 27 primetime games, a mixture of Sunday Night Baseball and holiday/special eventgames on NBC/ Peacock and Peacock/ NBCSN
* 34 afternoon games across NBC/Peacock and Peacock/NBCSN, highlighted by 18 MLB Sunday Leadoff games on Peacock, most with noon start times locally
* A Sunday afternoon whip-around show on Peacock following MLB Sunday Leadoff games, featuring look-ins at all the live action around Major League Baseball, plus a special final day of regular season whip-around show on Sunday, Sept. 27 on Peacock and NBCSN
* One out-of-market game each day of the season streamed nationally on Peacock
* Special July 5 "Star-Spangled Sunday" featuring all 15 MLB games exclusively presented nationally on Peacock and NBC
* Exclusive coverage of the entire Wild Card round ignites the MLB Postseason on NBC, Peacock and NBCSN (8-12 games)
With the addition of Sunday Night Baseball, NBC will deliver year-round primetime sports programming on the same night each week - a broadcast network first - joining NBC Sports' presentations of Sunday Night Football (NFL) and Sunday Night Basketball (NBA).
Highlights of NBC Sports' 2026 Major League Baseball Schedule
* Major League Baseball returns to NBC and Peacock with a showcase package of exclusive games and events highlighted by the World Series champion Los Angeles Dodgers raising their banner leading into a primetime matchup (vs. Arizona Diamondbacks) on March 26, 2026 - the first full day of games in the 2026 MLB season. The Dodgers' opener will be the only primetime MLB game on Opening Day.
* NBC Sports presents an Opening Day matinee (March 26 at 1 p.m. ET on NBC and Peacock), as 2025 NL Cy Young winner Paul Skenes and the Pittsburgh Pirates visit Juan Soto and the New York Mets.
* Sunday Night Baseball debuts March 29 at 7 p.m. ET on Peacock/NBCSN, with a matchup of American League division winners as the Cleveland Guardians visit the Seattle Mariners.
* MLB Sunday Leadoff on Peacock and NBCSN begins on May 3 as the American League champion Toronto Blue Jays visit the Minnesota Twins.
* 2025 MLB Postseason Clubs in primetime include four appearances apiece by the World Champion Los Angeles Dodgers, Boston Red Sox and San Diego Padres, and three primetime games each for the New York Yankees, Philadelphia Phillies, Detroit Tigers, and Seattle Mariners.
* In mid-July, young players will be highlighted as NBC and Peacock present early first-round coverage of the MLB Draft at 1:30 p.m. ET on Saturday, July 11, and the All-Star Futures Game at Noon ET on Sunday, July 12.
Division Rivalries in Primetime
Sunday Night Baseball will be home to division rivalry games including Diamondbacks-Dodgers (March 26); Braves-Phillies (April 19); Tigers-Royals (May 10); Rangers-Angels (May 24); Cubs-Cardinals (May 31); Mets-Phillies (June 21); Yankees-Red Sox (June 28); Padres-Dodgers (July 5); Mariners-Astros (August 16); and Padres-Giants (Sept. 13).
Spanish-Language Coverage for all NBCU-Produced Games
Universo will televise all games broadcast on NBC, and SAP will be provided for all games on Peacock.
2026 Sunday Night Baseball & Special Event Schedule
**All Times ET**
**NOTE: Most Peacock Exclusive Games Will Be Simulcast on NBCSN
Date
Time
Game
Platforms
March 26*
1 p.m.
Pittsburgh Pirates at N.Y. Mets
NBC/Peacock
March 26*
8 p.m.
Arizona Diamondbacks at L.A. Dodgers
NBC/Peacock
March 29
7 p.m.
Cleveland Guardians at Seattle Mariners
Peacock
April 5
7 p.m.
St. Louis Cardinals at Detroit Tigers
Peacock
April 12
7 p.m.
Cleveland Guardians at Atlanta Braves
NBC/Peacock
April 19
7 p.m.
Atlanta Braves at Philadelphia Phillies
Peacock
April 26
7 p.m.
L.A. Angels at Kansas City Royals
Peacock
May 3
7 p.m.
Texas Rangers at Detroit Tigers
Peacock
May 10
7 p.m.
Detroit Tigers at Kansas City Royals
Peacock
May 17
7 p.m.
San Diego Padres at Seattle Mariners
Peacock
May 24
7 p.m.
Texas Rangers at L.A. Angels
Peacock
May 31
7 p.m.
Chicago Cubs at St. Louis Cardinals
NBC/Peacock
June 7
8 p.m.
San Francisco Giants at Chicago Cubs
NBC/Peacock
June 14
7 p.m.
Texas Rangers at Boston Red Sox
NBC/Peacock
June 21
7 p.m.
N.Y. Mets at Philadelphia Phillies
NBC/Peacock
June 28
7 p.m.
N.Y. Yankees at Boston Red Sox
NBC/Peacock
July 5**
12:30 p.m.
N.Y. Mets at Atlanta Braves
NBC/Peacock
July 5
7 p.m.
San Diego Padres at L.A. Dodgers
NBC/Peacock
July 19
7 p.m.
L.A. Dodgers at N.Y. Yankees
NBC/Peacock
July 26
7 p.m.
N.Y. Yankees at Philadelphia Phillies
NBC/Peacock
August 2
7 p.m.
Boston Red Sox at L.A. Dodgers
NBC/Peacock
August 9
8 p.m.
Houston Astros at San Diego Padres
NBC/Peacock
August 16
7 p.m.
Seattle Mariners at Houston Astros
NBC/Peacock
August 23
3 p.m.
San Francisco Giants at Boston Red Sox
NBC/Peacock
August 30
3 p.m.
Cincinnati Reds at Chicago Cubs
NBC/Peacock
August 30
7 p.m.
Houston Astros at N.Y. Mets
NBC/Peacock
Sept. 6
3 p.m.
Atlanta Braves at Philadelphia Phillies
NBC/Peacock
Sept. 6
7 p.m.
Toronto Blue Jays at Kansas City Royals
Peacock
Sept. 7
8 p.m.
St. Louis Cardinals at San Francisco Giants
NBC/Peacock
Sept. 13
7 p.m.
San Diego Padres at San Francisco Giants
Peacock
Sept. 20
7 p.m.
Milwaukee Brewers at Baltimore Orioles
Peacock
*Opening Day (Thursday)
**Also on MLB Sunday Leadoff schedule ( below )
***Labor Day (Monday)
2026 MLB Sunday Leadoff Schedule
**All Times ET**
**NOTE: Most Peacock Exclusive Games Will Be Simulcast on NBCSN
Date
Time
Game
Platforms
May 3
12:30 p.m.
Toronto Blue Jays at Minnesota Twins
Peacock
May 10
Noon
Washington Nationals at Miami Marlins
Peacock
May 17
Noon
Miami Marlins at Tampa Bay Rays
Peacock
May 24
Noon
Pittsburgh Pirates at Toronto Blue Jays
Peacock
May 31
Noon
Toronto Blue Jays at Baltimore Orioles
Peacock
June 7
3 p.m.
Washington Nationals at Arizona Diamondbacks
Peacock
June 14
Noon
Miami Marlins at Pittsburgh Pirates
Peacock
June 21
3 p.m.
Minnesota Twins at Arizona Diamondbacks
Peacock
June 28
3 p.m.
Athletics at L.A. Angels
Peacock
July 5
12:30 p.m.
N.Y. Mets at Atlanta Braves
NBC/Peacock
July 12
Noon
Milwaukee Brewers at Pittsburgh Pirates
Peacock
July 19
Noon
Chicago White Sox at Toronto Blue Jays
Peacock
July 26
Noon
Cleveland Guardians at Tampa Bay Rays
Peacock
August 2
3 p.m.
Milwaukee Brewers at L.A. Angels
Peacock
August 9
Noon
Cincinnati Reds at Washington Nationals
Peacock
August 16
Noon
Baltimore Orioles at Tampa Bay Rays
Peacock
August 23
4 p.m.
Cincinnati Reds at Arizona Diamondbacks
Peacock
August 30
Noon
Miami Marlins at Washington Nationals
Peacock
NBC Sports' July 5 MLB "Star-Spangled Sunday"
Every MLB Game presented nationally on NBCUniversal platforms
**All Times ET**
**NOTE: Most Peacock Exclusive Games Will Be Simulcast on NBCSN
Time
Game
Platforms
12:30 p.m.*
N.Y. Mets at Atlanta Braves
NBC/Peacock
1 p.m.
Pittsburgh Pirates at Washington Nationals
Peacock
1 p.m.
Baltimore Orioles at Cincinnati Reds
Peacock
1:30 p.m.
Minnesota Twins at New York Yankees
Peacock
2 p.m.
Chicago White Sox at Cleveland Guardians
Peacock
2:30 p.m.
St. Louis Cardinals at Chicago Cubs
Peacock
3 p.m.
Philadelphia Philles at Kansas City Royals
Peacock
3:30 p.m.
Detroit Tigers at Texas Rangers
Peacock
3:30 p.m.
Tampa Bay Rays at Houston Astros
Peacock
4:00 p.m.
San Francisco Giants at Colorado Rockies
Peacock
4:00 p.m.
Milwaukee Brewers at Arizona Diamondbacks
Peacock
4:30 p.m.
Miami Marlins at Athletics
Peacock
5:00 p.m.
Toronto Blue Jays at Seattle Mariners
Peacock
7 p.m. **
San Diego Padres at L.A. Dodgers
NBC/Peacock
9:30 p.m.
Boston Red Sox at Los Angeles Angels
Peacock
* MLB Sunday Leadoff
** Sunday Night Baseball
***
Original text here: https://www.nbcuniversal.com/article/ohtani-judge-yankees-red-sox-dodgers-yankees-cubs-cardinals-and-additional-premium-matchups-headline
Optimum Mobile Expands Device Lineup With the All-New Samsung Galaxy Tab A11+ 5G and Samsung Galaxy A17 5G
LONG ISLAND CITY, New York, Jan. 10 -- Optimum, a subsidiary of Altice USA, issued the following news release:
* * *
Optimum Mobile Expands Device Lineup with the All-New Samsung Galaxy Tab A11+ 5G and Samsung Galaxy A17 5G
Optimum Mobile is excited to announce the addition of two new Samsung devices to its portfolio: the Samsung Galaxy Tab A11+ 5G and the Samsung Galaxy A17 5G, delivering next-generation connectivity and productivity to customers nationwide.
The Samsung Galaxy Tab A11+ 5G features a vibrant 11" display, industry-leading processor, and advanced Galaxy AI capabilities designed
... Show Full Article
LONG ISLAND CITY, New York, Jan. 10 -- Optimum, a subsidiary of Altice USA, issued the following news release:
* * *
Optimum Mobile Expands Device Lineup with the All-New Samsung Galaxy Tab A11+ 5G and Samsung Galaxy A17 5G
Optimum Mobile is excited to announce the addition of two new Samsung devices to its portfolio: the Samsung Galaxy Tab A11+ 5G and the Samsung Galaxy A17 5G, delivering next-generation connectivity and productivity to customers nationwide.
The Samsung Galaxy Tab A11+ 5G features a vibrant 11" display, industry-leading processor, and advanced Galaxy AI capabilities designedto simplify everyday tasks. With lightning-fast 5G connectivity, users can stream, work, and play wherever life takes them. Key features include an immersive FHD+ display, a powerful 4nm processor, and enhanced battery life for all-day productivity. The new Galaxy AI features support smarter organization, translation, and creativity, all within a sleek, modern design perfect for work, school, and entertainment.
The Samsung Galaxy A17 5G brings incredible value and essential features at an awesome price. Capture precious memories in vivid colors and clarity with its enhanced triple-lens camera and Optical Image Stabilization. Stream your favorite movies and shows on its crystal-clear 6.7" Super AMOLED display. With the power of AI, including Gemini and Circle to Search, planning events, making reservations, and finding gifts is easier than ever. Enjoy reliable Super Fast Charging, up to 2TB of expandable storage, and ultra-fast 5G to stay connected. Additional perks include Samsung Wallet, Samsung TV Plus, and 6 OS upgrades with 6 years of security updates for lasting protection and value.
Both devices are now available online and in Optimum retail stores, joining the latest Samsung Galaxy S Series in Optimum's growing lineup of premium devices.
The Samsung Galaxy Tab A11+ 5G joins the portfolio of tablets available at Optimum Mobile which delivers affordable mobile and tablet plans on America's largest and fastest 5G network. Customers can get a Tablet Unlimited plan for just $10/month for 12 months when customers add a new line of Tablet Unlimited and finance the new tablet. This offer is available to new and existing Optimum Mobile customers through January 22, 2026.
For complete pricing and availability details, please visit Optimum.com/mobile or an Optimum store.
* * *
Original text here: https://www.optimum.com/about-us/news/articles/optimum-mobile-expands-device-lineup-all-new-samsung-galaxy-tab-a11-5g-and-samsung
[Category: BizComputer Technology]
Morgan Stanley Appoints 184 New Managing Directors
NEW YORK, Jan. 10 -- Morgan Stanley, a multinational financial services corporation, issued the following news release:
* * *
Morgan Stanley Appoints 184 New Managing Directors
Morgan Stanley (NYSE: MS) has announced the appointment of 184 Managing Directors. The new Managing Directors are:
Sahil Aggarwal
Jason B. Lynch
Meg Angeles-Dayrit
Jon Mace
Lauren Ares
Paul Madenjian
Sara Banelli
Dave Magoloff
Arjun Bathla
Anthony Maiorano
Michael Beilstein
Steven Markarian
Aditya Bhatla
Paolo Mattiello
Carolee Boles
Lyndal May
Gilbert Borrmann
Kelly McCarthy
William Boyle
Cameron
... Show Full Article
NEW YORK, Jan. 10 -- Morgan Stanley, a multinational financial services corporation, issued the following news release:
* * *
Morgan Stanley Appoints 184 New Managing Directors
Morgan Stanley (NYSE: MS) has announced the appointment of 184 Managing Directors. The new Managing Directors are:
Sahil Aggarwal
Jason B. Lynch
Meg Angeles-Dayrit
Jon Mace
Lauren Ares
Paul Madenjian
Sara Banelli
Dave Magoloff
Arjun Bathla
Anthony Maiorano
Michael Beilstein
Steven Markarian
Aditya Bhatla
Paolo Mattiello
Carolee Boles
Lyndal May
Gilbert Borrmann
Kelly McCarthy
William Boyle
CameronMcCarthy
Eric Bradbury
Eric McConnell
Lucy Callaghan
Michael McGillen
Gerard Campbell
James McNichol
Alessandro Caruso
Carien Meintjes
Todd Castagno
Yosuke Morikawa
Nicole Castellano
James Morphis
Sidharth Chaturvedi
Roly Morris
Eric Cheung
Daniel Murphy
Elitza Christoff
Rob Murray III
Elizabeth Cioffi
Neelesh Nath
Dan Codreanu
Anuradha Nath
Madhu Coimbatore
Nick Nocito
Tristan Collier
Michael O'Byrne
Tom Cresswell
Tim O'Connor
Meredith Curley Shaw
Takamasa Ochi
Nicole De Bello
Jeannie Oen
Patrick Deane
Johan Olofsson
Paolo Della Rovere
Hilary Ann O'Neill
Tara Denley
Jim Paolillo
Ronke Desalu-Dottin
Vishwas Patkar
Dominick DiMeo
Ricardo Penades Ruiz
Tommaso Dondi
Seth A. Perlman
Michael Dong
Andre Hassin Pinto
Etim E. Edim
Ethan Plater
Dana Erdfarb
David Pringle
Omer Erkovan
Monica Qin
Michael Escott
Jami Badr Quraishi
Joseph Esposito
Akhilesh Raina
Diogo Fagliari
Joshua Reichert
Andrew Farmer
Ricardo Rivera Saad
Simon Ferguson
Anthony Rizzi
Ted Finan
Jennifer Robertson
Kevin M. Fitzpatrick
Joanna Rogowska
Takayuki Furukawa
Nick Romero
Alain Gabriel
Rich Rooney
Catherine Gagnon
Eric Rosenblum
Pilar Garicano
Tanmay Sachan
Adam Gaspar
Kathleen Salvaty
Nishant Gaurav
Akshat Sarwal
Shailesh Gavankar
Thomas Scallon
Ziad Gemayel
David Schoenfeld
Nicholas George
Utkarsh Sharma
Salvatore Giglio
Brian Shaw
Alfonso Gomez-Acebo Lopez
Bert Shen
Juan Gonzalez Paris
Amol Shukla
Casey Gough
D. Rajeev Sibal
Mary Walker Goza
Ariane Silva
Venkat Guduru
Silky Singh
Ben Hamdani
Bart Sitarz
Christopher O. Hathaway
Meredith Skowronski
David Herssein
Alex Smart
Kyle Holder
Brian C. Smith
Diane Hollinger
Ian Stuart
Tim Hsiao
Kyle Sultzer
Carol Hu Lucero
Ning Sun
Amy R. Husseini
Steve Sun
Olivier Jacque
Greg Tarca
Saba Jafri
Shaan Tehal
Shubham Jain
Riccardo Tessari
Mariel Jenkins Taylor
Phil Torrisi
Mark Jones
Brietta Tsang
Kenneth Judy
Brian Turkfeld
Stacey Juliano
Iris van Heerdt
Shamil Karia
Alexander van Holk
Amr Karim
Hector Vazquez
Sean Keresey
Krithika Venkat
Hilal Khan
Thiru Venkatachalam
Phillip P. Kim
Maya Venkatraman
Erin M. Korte
Liensa Vidra
Rishi Kripalani
Elrika Vlok
Marc Krupinski
Dessi Volpicelli
Ken Lahav
Minoo F. Wade
Kristine Larracas
Fenix Wang
Boris Lerner
Neil Ward
Yanny Leung
Sean M. Waters
Melissa Levine
Andrew Willersdorf
Richard R. Lindquist
Peter Wilson
Andrew Lipton
Austin Zeigler
Kristine T. Liwag
Shuai Zhang
Franco A. Lofaro
Eva L. Zhong
Hilda Loong
Mario A. Zillner
Andrew Lunney
Anna Zou
* * *
Morgan Stanley is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 countries, the Firm's employees serve clients worldwide including corporations, governments, institutions and individuals. For further information about Morgan Stanley, please visit www.morganstanley.com.
* * *
Original text here: https://www.morganstanley.com/press-releases/morgan-stanley-appoints-184-new-managing-directors0
[Category: BizFinancial Services]
Marcus & Millichap Brokers Sale of $14.3M Grocery-Anchored Center in Rocky Hill, Connecticut Despite Complex CMBS Loan Assumption
ENCINO, California, Jan. 10 -- Marcus and Millichap issued the following news release:
* * *
Marcus & Millichap Brokers Sale of $14.3M Grocery-Anchored Center in Rocky Hill, Connecticut Despite Complex CMBS Loan Assumption
ROCKY HILL, Conn., Jan. 9, 2026 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of Big Y Plaza, a 60,947-square-foot grocery-anchored shopping center in Rocky Hill, Connecticut, for $14.3 million.
Marcus & Millichap's Joseph C. French Jr.
... Show Full Article
ENCINO, California, Jan. 10 -- Marcus and Millichap issued the following news release:
* * *
Marcus & Millichap Brokers Sale of $14.3M Grocery-Anchored Center in Rocky Hill, Connecticut Despite Complex CMBS Loan Assumption
ROCKY HILL, Conn., Jan. 9, 2026 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of Big Y Plaza, a 60,947-square-foot grocery-anchored shopping center in Rocky Hill, Connecticut, for $14.3 million.
Marcus & Millichap's Joseph C. French Jr.and Jeffrey Stearney, in association with John Krueger, the firm's broker of record in Connecticut, exclusively marketed the property on behalf of the seller, a private Connecticut-based company, and procured the buyer, a private New York-based investor.
"The Big Y Plaza has changed hands in a transaction that exemplifies perseverance and collaboration," said French. "The sale was uniquely challenging due to the assumption of an existing commercial mortgage-backed securities loan, a process that required months of approvals and coordination among multiple stakeholders. Despite the extended timeline, both the within the Hartford metropolitan region, providing access for both local and commuter traffic. buyer and seller remained committed to completing the transaction. The successful closing underscores the parties' ability to navigate the complexities of structured financing."
Built in 1988, Big Y Plaza is located at 1030 Elm St. and is fully occupied by two tenants, Big Y Supermarket and Wells Fargo Bank. The center sits on approximately 14.1 acres and includes surface parking. The property is near Interstate 91 and serves a dense residential trade area.
* * *
About Marcus & Millichap, Inc. (NYSE: MMI)
Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. As of December 31, 2024, the company had 1,712 investment sales and financing professionals in over 80 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate. The company also offers market research, consulting and advisory services to clients. Marcus & Millichap closed 7,836 transactions in 2024, with a sales volume of approximately $49.6 billion. For additional information, please visit www.MarcusMillichap.com.
* * *
Original text here: https://www.marcusmillichap.com/news-events/press/2026/01/1-9-big-y-plaza
[Category: BizRealEstate]
Marcus & Millichap Arranges $10.4M Sale of Downtown Winter Garden Mixed-Use Asset
ENCINO, California, Jan. 10 -- Marcus and Millichap issued the following news release:
* * *
Marcus & Millichap Arranges $10.4M Sale of Downtown Winter Garden Mixed-Use Asset
WINTER GARDEN, Fla., Jan. 9, 2026 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the $10.4 million sale of Tremaine | Boyd, a mixed-use property consisting of luxury residential units and ground-floor commercial space in Winter Garden, Florida.
The sale of Tremaine Boyd was driven by both the
... Show Full Article
ENCINO, California, Jan. 10 -- Marcus and Millichap issued the following news release:
* * *
Marcus & Millichap Arranges $10.4M Sale of Downtown Winter Garden Mixed-Use Asset
WINTER GARDEN, Fla., Jan. 9, 2026 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the $10.4 million sale of Tremaine | Boyd, a mixed-use property consisting of luxury residential units and ground-floor commercial space in Winter Garden, Florida.
The sale of Tremaine Boyd was driven by both thequality of the asset and the continued evolution of downtown Winter Garden as a premier mixed-use destination. "The buyer was drawn to more than just the real estate, they were investing in Winter Garden's story and its long-term growth," said Matthew Prozzillo, Senior Director Investments. "As the original developer, the seller created a landmark asset that helped shape downtown Winter Garden's evolution, making this transaction both a strategic acquisition for the buyer and a successful, vision-validated exit for the seller."
That alignment between asset quality and market fundamentals translated into strong investor demand throughout the marketing process. "The depth and quality of investor interest in Tremaine | Boyd was exceptional, with 19 offers generated in a compressed marketing window from both local and institutional capital," said Ben Skinner, Senior Director Investments. "Achieving a record-setting price per unit for the Orlando MSA underscores the scarcity of true mixed-use product in downtown Winter Garden and the conviction investors have in this market's long-term trajectory."
Prozzillo, Skinner, Alex Goodale and Salim Valiani, investment specialists in Marcus & Millichap's Orlando office, exclusively marketed the property on behalf of the seller, who was the original developer, and procured the buyer, a New York-based family office.
Built in 2019, the three-story property is located at 109 S. Boyd St. in historic downtown Winter Garden. The asset includes 22 residential units, with two commercial tenants occupying the ground floor. The property is one block off Plant Street, the city's primary commercial corridor, adjacent to the SOBO Art Gallery and directly across from the nationally recognized Winter Garden Farmers Market.
* * *
About Marcus & Millichap, Inc. (NYSE: MMI)
Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. As of December 31, 2024, the company had 1,712 investment sales and financing professionals in over 80 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate. The company also offers market research, consulting and advisory services to clients. Marcus & Millichap closed 7,836 transactions in 2024, with a sales volume of approximately $49.6 billion. For additional information, please visit www.MarcusMillichap.com.
* * *
Original text here: https://www.marcusmillichap.com/news-events/press/2026/01/1-9-tremaine-boyd
[Category: BizRealEstate]
Littler: Policy Week in Review - Jan. 9, 2026
SAN FRANCISCO, California, Jan. 10 -- Littler, a law firm, issued the following news:
* * *
Policy Week in Review - January 9, 2026
Congressional and Administrative News
At a Glance
The Policy Week in Review, prepared by Littler's Workplace Policy Institute (WPI), sets forth WPI's updates on federal, state, and local matters.
By Shannon Meade, Jim Paretti, Alex MacDonald and Maury Baskin
NLRB Has a Quorum!
On January 7, Senate-confirmed National Labor Relations Board (NLRB) nominees James Murphy and Scott Mayer were sworn in as new Board members, giving the Board a 2-1 Republican majority.
... Show Full Article
SAN FRANCISCO, California, Jan. 10 -- Littler, a law firm, issued the following news:
* * *
Policy Week in Review - January 9, 2026
Congressional and Administrative News
At a Glance
The Policy Week in Review, prepared by Littler's Workplace Policy Institute (WPI), sets forth WPI's updates on federal, state, and local matters.
By Shannon Meade, Jim Paretti, Alex MacDonald and Maury Baskin
NLRB Has a Quorum!
On January 7, Senate-confirmed National Labor Relations Board (NLRB) nominees James Murphy and Scott Mayer were sworn in as new Board members, giving the Board a 2-1 Republican majority.The Board now has the requisite quorum needed to clear the backlog of cases and start issuing decisions. Murphy, who will serve as Board chair, will have a term that expires on December 16, 2027, while Mayer's term will expire on December 16, 2029. At this time, a third Republican nominee has yet to be named and confirmed, which means the Board may adhere to its longstanding policy of not changing precedent without three votes in the affirmative. Additionally, Crystal Carey was sworn in as the Board's general counsel for a four-year term. Read here for Littler's insight.
U.S. DOL's Wage and Hour Division Issues Six New Opinion Letters
On January 5, the U.S. Department of Labor's Wage and Hour Division (WHD) issued six new opinion letters intended to provide meaningful compliance assistance to the regulated community on how the Department's regulations apply to specific workplace situations. Four of the letters respond to questions related to Fair Labor Standards Act (FLSA) compliance, including:
FLSA2026-1: Whether an employee's role meets the criteria for the learned professional exemption under section 13(a)(1) of the FLSA, and, if so, whether an employer is nevertheless permitted to reclassify the employee as non-exempt. Read Littler's analysis here.
FLSA2026-2: Whether section 7(e) of the FLSA permits an employer to exclude certain bonus payments from an employee's regular rate of pay. The letter also addresses how to include these payments in the calculation of employee overtime premiums if the payments must be included in an employee's regular rate of pay. Read Littler's analysis here.
FLSA2026-3: Whether a union and employer can enter into a collective bargaining agreement that mandates a 15-minute "roll call" prior to each scheduled shift but excludes that time when calculating overtime premiums under the FLSA. Read Littler's analysis here.
FLSA2026-4: Whether, for purposes of the overtime exemption for certain commissioned employees in section 7(i) of the FLSA, an employer in a jurisdiction in which the state minimum wage exceeds the federal minimum wage must use the federal minimum wage, or alternatively, the higher state minimum wage, to determine whether it has satisfied the minimum pay standard in section 7(i)(1), and whether tips are deemed compensation for purposes of section 7(i)(2)'s requirement that more than half the employee's compensation consist of commissions. Read Littler's analysis here.
The other two letters respond to questions related to the Family Medical Leave Act (FMLA) compliance, including:
FMLA2026-1: How a school closure of less than a full week impacts the amount of leave a school employee uses under the FMLA.
FMLA2026-2: Whether FMLA leave may be used for time spent traveling to or from medical appointments, including where an employee provided the employer with medical certification from a health care provider that confirms the employee's need for the appointment, but the certification does not address travel to or from the appointment.
Opinion letters issued by the Department's WHD are official publications that explain how the DOL enforces various laws and regulations under specific scenarios submitted by a requesting party. Opinion letters offer timely guidance to both employers and individuals, while also providing insight into the agency's likely positions in future rulemaking or litigation. While they do not override existing statutes or regulations, they provide authoritative guidance that can help employers and individuals navigate compliance with greater confidence. Employers that rely on an opinion letter in good faith may use that reliance as a defense against potential liability, liquidated damages, and an extension of the statute of limitations to three years for an alleged willful violation under the Fair Labor Standards Act. Read here for further Littler guidance.
Proposed Independent Contractor Rule at OIRA
The White House Office of Information and Regulatory Affairs (OIRA) yesterday received a proposed rule from the U.S. Department of Labor's Wage and Hour Division (WHD) relating to employee or independent contractor status under the Fair Labor Standards Act (FLSA), Family and Medical Leave Act (FMLA), and Migrant and Seasonal Agricultural Worker Protection Act (MSAWPA). It is unclear if this proposal is simply a rescission of the Biden administration rule; a rescission of the Biden rule and replacement with a rule from first Trump administration; or something else entirely. Assuming OIRA has no significant changes, the Department can then move ahead and publish the proposed rule. OIRA's review time can vary widely, but if this proposal is a rescission and/or rescind and replace with a prior Trump rule, we may see a proposed rule for public comment in the near future. WPI will keep clients apprised as we learn more information.
Chair Walberg to Hold Hearing on Artificial Intelligence
House Education and Workforce Committee Chair Tim Walberg will hold the first hearing in a series to examine the impacts of artificial intelligence (AI) on the American workforce. The hearing, titled "Building an AI-Ready America," is scheduled for Wednesday, January 14 at 10:15 a.m. ET and will be live-streamed on the Committee's YouTube page.
Administration Releases Additional H-2B Visas
The U.S. Departments of Labor and Homeland Security announced last week they will make an additional 35,000 H-2B temporary nonagricultural workers visas available for FY2026 (on top of the congressionally mandated 66,000 H-2B visas that are available each fiscal year) to support American businesses with seasonal or temporary workforce needs in critical infrastructure sectors of the economy. The Departments will release the additional visas, including eligibility criteria and filing requirements, in the coming weeks via a temporary final rule published in the federal register.
* * *
Authors
Shannon Meade
Executive Director, Workplace Policy Institute
Washington, D.C.
* * *
James A. Paretti
Shareholder
Washington, D.C.
* * *
Alexander T. MacDonald
Shareholder
Washington, D.C.
* * *
Maury Baskin
Shareholder
Washington, D.C.
* * *
Original text here: https://www.littler.com/news-analysis/asap/policy-week-review-january-9-2026
[Category: BizLaw/Legal]
Hooper, Lundy and Bookman Issues Commentary: FDA's New Digital Health Guidance Signal Shift for Wellness Devices and CDS
LOS ANGELES, California, Jan. 10 -- Hooper, Lundy and Bookman, a law firm, issued the following commentary on Jan. 9, 2026:
* * *
FDA's New Digital Health Guidance Signal Shift for Wellness Devices and CDS
On January 6, 2026, the Food and Drug Administration (FDA) released updated guidance on Clinical Decision Support Software, as well as General Wellness: Policy for Low Risk Devices, providing clarity to an industry grappling with innovation and regulatory expectations. Both guidance documents contain additional explanation from the FDA on the definitions and applicable regulations which apply
... Show Full Article
LOS ANGELES, California, Jan. 10 -- Hooper, Lundy and Bookman, a law firm, issued the following commentary on Jan. 9, 2026:
* * *
FDA's New Digital Health Guidance Signal Shift for Wellness Devices and CDS
On January 6, 2026, the Food and Drug Administration (FDA) released updated guidance on Clinical Decision Support Software, as well as General Wellness: Policy for Low Risk Devices, providing clarity to an industry grappling with innovation and regulatory expectations. Both guidance documents contain additional explanation from the FDA on the definitions and applicable regulations which applyto general wellness products and clinical decision support (CDS) software. While FDA notes the guidance is nonbinding and merely represents the FDA's current recommendations and statutory interpretations, it is intended to provide an understanding of what enforcement actions the Administration will undertake. The guidance is part of a larger initiative from the Trump Administration to both deregulate and encourage use of digital health products. Although the guidance limits those products under FDA's regulatory purview, it will be important for providers to be aware of where their devices fall within regulatory definitions as the digital health policy landscape continues to adapt to its current pressures through further policymaking.
General Wellness Products
The FDA's Center for Devices and Radiological Health released updated guidance (last revised in 2019) for low-risk general wellness products. The agency specifically defines general wellness products as those that relate to maintaining a general state of health or the role of a healthy lifestyle to reduce the risk of certain chronic diseases. These products also must present a low risk to the safety of users.
Building off its previous guidance, FDA describes its categories of intended uses in two ways, (1) those claiming to sustain or improve functions associated with a general state of health that do not make any reference to diseases or condition, such as weight management, physical fitness, stress management, mental acuity, self-esteem, sleep management or sexual function and (2) those that make reference to diseases or conditions and are intended to help reduce the risk of and manage certain chronic conditions. The FDA guidance establishes a standard that products must not be invasive, implanted, or pose a risk to the safety of the user.
The guidance responds to an increased need for clarification that certain non invasive sensing features in wearables--such as optical sensors that estimate blood pressure, oxygen saturation, blood glucose trends, or heart rate variability--may be treated as general wellness products, rather than medical devices, when the products are intended only for wellness-related use. The FDA provides specific examples of wrist-warn wearables and their applications.
The FDA emphasized that the goal of the guidance is to give companies clear boundaries so that devices that simply provide information--without presenting themselves as medical-grade tools--can operate without FDA oversight. This effort aligns with the Administration's interest in the use of wearables as part of its Make America Health Again initiative, seeking to use innovative means to manage and prevent chronic disease and overall health.
Clinical Decision Support Software
Additionally, FDA released updated guidance (last revised in 2022) outlining a more permissive approach to certain types of clinical decision support (CDS) software, signaling a notable shift from its earlier regulatory stance. The new guidance specifies categories of lower risk CDS tools that will fall outside the scope of medical device regulation, while also clarifying which software functions will continue to be treated as devices.
To qualify as a non device function and therefore not be subject to FDA regulation, CDS software must be:
1. "not intended to acquire, process, or analyze a medical image or a signal from an in vitro diagnostic device or a pattern or signal from a signal acquisition system;
2. intended for the purpose of displaying, analyzing, or printing medical information about a patient or other medical information;
3. intended for the purpose of supporting or providing recommendations to a health care professional about prevention, diagnosis, or treatment of a disease or condition; and
4. intended for the purpose of enabling such health care professional to independently review the basis for such recommendations that such software presents so that it is not the intent that such health care professional rely primarily on any of such recommendations to make a clinical diagnosis or treatment decision regarding an individual patient."
The new guidance clarifies the third criterion for CDS software functions that are excluded from the definition of a medical device under the Food, Drug and Cosmetic Act. The FDA will not enforce regulatory requirements for software that provides a single clinically appropriate recommendation, provided the other criteria are met. Previously, non-device software could only provide a list of treatment recommendations. FDA lists examples that would be subject to enforcement discretion.
Under the FDA guidance, examples of non-device CDS functions include tailored clinician order sets, matching patient medical information, drug formulary guidelines, drug interaction notifications, reminders for preventative care, patient discharge papers, and lists of follow-up options. Examples of items that remain within medical device oversight include software that uses patient images to generate treatment plans, tools that analyze imaging data for surgical planning, and systems that process multiple physiological signals from wearables to detect events such as heart attacks or narcolepsy episodes.
Outlook
The guidance further underscores the Trump Administration's efforts to promote digital health innovation, building on prior announcements, such as the FDA's Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot and the Center for Medicare and Medicaid Innovation's (CMMI's) Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model which would expand access to new technology-supported care to manage chronic disease. Of note, both updated guidance documents were issued without an opportunity to comment beforehand, limiting input. Stakeholders may submit comments for the FDA to consider at any time, but those comments may not be acted upon by the agency until the document is next revised or updated.
-- Monica Massaro and Claire Ernst
* * *
Professional
Monica Massaro
Principal, Government Relations & Public Policy
Washington, D.C.
* * *
Claire Ernst
Director, Government Relations & Public Policy
Washington, D.C.
* * *
Original text here: https://hooperlundy.com/fdas-new-digital-health-guidance-signal-shift-for-wellness-devices-and-cds/
[Category: BizLaw/Legal]